CD4 and telomere syndrome: Consistent with our previous findings, STS patients showed a significant increase in circulating CD8+ T cells and a slight decrease in CD4+ T cells compared with healthy donors, in line with reports of elevated antigen-specific CD8+ T cells in cancer patients (13, 22, 23), which is more evident in P3 patients.